Products & Services

Dr. Björn Drobe Discusses Four-Year Results of Essilor Stellest Lenses

sponsored content

February 1, 2024

Review of Myopia Management’s Editor-in-Chief John Sailer recently interviewed Dr. Björn Drobe, the Director of R&D Vision Science Asia at EssilorLuxottica, to learn more about the company’s Essilor Stellest lenses for myopia control. In this discussion, Dr. Drobe talks about the design of the company’s four-year clinical trial for the Essilor Stellest lenses, including the results, which show the lens’ ongoing efficacy of slowing myopia progression and axial elongation in children.

Listen to the full interview to learn more about the importance of patient compliance, the data on the potential rebound effect for children wearing Essilor Stellest lenses, the company’s virtual control group in the fourth year of the trial, and more:



1 Drobe B, Xue L, Huang Y, Lim EW, Bao J. Spectacle lenses with highly aspherical lenslets for myopia control: 4-year clinical trial results. Investigative Ophthalmology & Visual Science. 2023;64(8):4162. Presented at the 2023 ARVO Annual Meeting, New Orleans

2 Wong YL, Li X, Huang Y, Yuan Y, Ye Y, Lim EW, Yang A, Spiegel DP, Drobe B, Bao J, Chen H. Eye growth pattern of myopic children wearing spectacle lenses with aspherical lenslets compared with non-myopic children. Ophthalmic Physiol Opt. 2024;44(1):206-213. 1–8.

3 Wong YL, Yuan Y, Su B, Tufail S, Ding Y, Ye Y, Paille D, Drobe B, Chen H, Bao J. Prediction of myopia onset with refractive error measured using non-cycloplegic subjective refraction: the WEPrOM Study. BMJ Open Ophthalmol. 2021;6(1):e000628. doi: 10.1136/bmjophth-2020-000628.

4 Yuan Y, Su B, Yang D, Wong YL, Bao J, Drobe B, Li M, Chen H. Changes of refraction, visual function and ocular biometrics of schoolchildren: Follow-up data of the WEPrOM Study in Wenzhou, China. Investigative Ophthalmology & Visual Science. 2019;60(9):5852

5 Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen, H. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmology. 2022;140(5):472-8. DOI:10.1001/jamaophthalmol.2022.0401

6 Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, Tan D. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113(12):2285-91.

7 Sankaridurg P, Weng R, Tran H, Spiegel DP, Drobe B, Ha T, Tran YH, Naduvilath T. Spectacle Lenses With Highly Aspherical Lenslets for Slowing Myopia: A Randomized, Double-Blind, Cross-Over Clinical Trial. American Journal of Ophthalmology. 2023;247:18-24. DOI:

8 Shamp W, Brennan NA, Bullimore MA, Cheng X, Maynes E. Influence of age and race on axial elongation in myopic children. Investigative Ophthalmology & Visual Science. 2022;63(7):257-A0111.

9 Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Progress in Retinal and Eye Research. 2021;83:100923

To Top